Jushi Holdings Inc. (JUSH) stock
JUSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.49−0.03 (-5.50%)
Close on Oct 19, 2026Market cap $98.11MP/E –Yield –
Jushi ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Jushi's ebitda for the twelve months ending Sep 30, 2026 was $38.47M, up 13.4% year over year. For fiscal 2025 it was $35.84M, down 12.1% from the year before. The highest annual figure on record is $40.75M in fiscal 2024.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.84M | -12.1% |
| FY2024 | Dec 31, 2024 | $40.75M | +71.4% |
| FY2023 | Dec 31, 2023 | $23.77M | – |
| FY2022 | Dec 31, 2022 | -$193.84M | – |
| FY2021 | Dec 31, 2021 | -$27.35M | – |
| FY2020 | Dec 31, 2020 | -$12.13M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $11.02M | +8.8% |
| Q2 FY2026 | Jun 30, 2026 | $9.95M | -14.0% |
| Q1 FY2026 | Mar 31, 2026 | $9.53M | +54.6% |
| Q4 FY2025 | Dec 31, 2025 | $7.97M | +31.4% |
| Q3 FY2025 | Sep 30, 2025 | $10.13M | +27.5% |
| Q2 FY2025 | Jun 30, 2025 | $11.57M | -26.7% |
| Q1 FY2025 | Mar 31, 2025 | $6.16M | -43.7% |
| Q4 FY2024 | Dec 31, 2024 | $6.07M | +2106.5% |
| Q3 FY2024 | Sep 30, 2024 | $7.95M | -8.0% |
| Q2 FY2024 | Jun 30, 2024 | $15.78M | +57.4% |
| Q1 FY2024 | Mar 31, 2024 | $10.96M | +127.1% |
| Q4 FY2023 | Dec 31, 2023 | $275.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $8.64M | – |
| Q2 FY2023 | Jun 30, 2023 | $10.03M | – |
| Q1 FY2023 | Mar 31, 2023 | $4.82M | – |
| Q4 FY2022 | Dec 31, 2022 | -$128.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$42.39M | -10566.2% |
| Q2 FY2022 | Jun 30, 2022 | -$7.72M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.95M | – |
| Q4 FY2021 | Dec 31, 2021 | -$22.91M | – |
| Q3 FY2021 | Sep 30, 2021 | $405.00K | – |
See a number that looks wrong?